eMedI Chat
Rebif® (interferon beta-1a) subcutaneous injection
Product Labeling
Safety Data Sheet
Patient Resources
Research
Additional Neurology Resources
- National Multiple Sclerosis Society
- Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)
- American Academy of Neurology (AAN)
- Consortium of Multiple Sclerosis Centers (CMSC)
- European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
- Press Releases
MS LifeLines and Rebif are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.






